AORT
Price
$25.41
Change
+$0.05 (+0.20%)
Updated
Feb 28 closing price
Capitalization
873.56M
61 days until earnings call
BSX
Price
$103.79
Change
+$2.99 (+2.97%)
Updated
Feb 28 closing price
Capitalization
100.1B
53 days until earnings call
Ad is loading...

AORT vs BSX

Header iconAORT vs BSX Comparison
Open Charts AORT vs BSXBanner chart's image
Artivion
Price$25.41
Change+$0.05 (+0.20%)
Volume$568.54K
Capitalization873.56M
Boston Scientific
Price$103.79
Change+$2.99 (+2.97%)
Volume$8.83M
Capitalization100.1B
AORT vs BSX Comparison Chart
Loading...
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AORT vs. BSX commentary
Mar 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a Hold and BSX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 01, 2025
Stock price -- (AORT: $25.41 vs. BSX: $103.79)
Brand notoriety: AORT: Not notable vs. BSX: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AORT: 149% vs. BSX: 139%
Market capitalization -- AORT: $873.56M vs. BSX: $100.1B
AORT [@Medical Specialties] is valued at $873.56M. BSX’s [@Medical Specialties] market capitalization is $100.1B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AORT’s FA Score shows that 0 FA rating(s) are green whileBSX’s FA Score has 2 green FA rating(s).

  • AORT’s FA Score: 0 green, 5 red.
  • BSX’s FA Score: 2 green, 3 red.
According to our system of comparison, BSX is a better buy in the long-term than AORT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AORT’s TA Score shows that 4 TA indicator(s) are bullish while BSX’s TA Score has 3 bullish TA indicator(s).

  • AORT’s TA Score: 4 bullish, 6 bearish.
  • BSX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BSX is a better buy in the short-term than AORT.

Price Growth

AORT (@Medical Specialties) experienced а -10.08% price change this week, while BSX (@Medical Specialties) price change was -0.67% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.38%. For the same industry, the average monthly price growth was -6.04%, and the average quarterly price growth was +5.95%.

Reported Earning Dates

AORT is expected to report earnings on May 01, 2025.

BSX is expected to report earnings on Apr 23, 2025.

Industries' Descriptions

@Medical Specialties (-3.38% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($100B) has a higher market cap than AORT($874M). AORT has higher P/E ratio than BSX: AORT (434.78) vs BSX (63.64). BSX YTD gains are higher at: 16.200 vs. AORT (-11.123). BSX has higher annual earnings (EBITDA): 3.45B vs. AORT (26.8M). BSX has more cash in the bank: 865M vs. AORT (58.9M). AORT has less debt than BSX: AORT (358M) vs BSX (9.49B). BSX has higher revenues than AORT: BSX (14.2B) vs AORT (354M).
AORTBSXAORT / BSX
Capitalization874M100B1%
EBITDA26.8M3.45B1%
Gain YTD-11.12316.200-69%
P/E Ratio434.7863.64683%
Revenue354M14.2B2%
Total Cash58.9M865M7%
Total Debt358M9.49B4%
FUNDAMENTALS RATINGS
AORT vs BSX: Fundamental Ratings
AORT
BSX
OUTLOOK RATING
1..100
5279
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
1004
SMR RATING
1..100
8569
PRICE GROWTH RATING
1..100
6242
P/E GROWTH RATING
1..100
7922
SEASONALITY SCORE
1..100
5055

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BSX's Valuation (82) in the Medical Specialties industry is in the same range as AORT (95). This means that BSX’s stock grew similarly to AORT’s over the last 12 months.

BSX's Profit vs Risk Rating (4) in the Medical Specialties industry is significantly better than the same rating for AORT (100). This means that BSX’s stock grew significantly faster than AORT’s over the last 12 months.

BSX's SMR Rating (69) in the Medical Specialties industry is in the same range as AORT (85). This means that BSX’s stock grew similarly to AORT’s over the last 12 months.

BSX's Price Growth Rating (42) in the Medical Specialties industry is in the same range as AORT (62). This means that BSX’s stock grew similarly to AORT’s over the last 12 months.

BSX's P/E Growth Rating (22) in the Medical Specialties industry is somewhat better than the same rating for AORT (79). This means that BSX’s stock grew somewhat faster than AORT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AORTBSX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
29%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
40%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
49%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
43%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 25 days ago
76%
Bullish Trend 20 days ago
63%
Declines
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 5 days ago
44%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Ad is loading...
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSHP5.450.14
+2.64%
Himalaya Shipping Ltd
COLB26.730.42
+1.60%
Columbia Banking System
NWG12.230.09
+0.74%
NatWest Group plc
HKIT1.22-0.01
-0.81%
Hitek Global
TUYA3.40-0.28
-7.61%
Tuya

AORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with SIBN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then SIBN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
+0.20%
SIBN - AORT
44%
Loosely correlated
+1.74%
SONVY - AORT
42%
Loosely correlated
-0.22%
LIVN - AORT
40%
Loosely correlated
+1.73%
BSX - AORT
40%
Loosely correlated
+2.97%
LMAT - AORT
40%
Loosely correlated
-7.90%
More

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been loosely correlated with ISRG. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+2.97%
ISRG - BSX
56%
Loosely correlated
+1.66%
SYK - BSX
53%
Loosely correlated
-0.70%
RVTY - BSX
52%
Loosely correlated
+1.54%
EW - BSX
43%
Loosely correlated
+0.31%
NTRA - BSX
36%
Loosely correlated
-0.65%
More